Hydrocortisone for COVID-19: living meta-analysis of clinical studies

Study explorer (study characteristics and results) method abbreviations pdf xlsx

display ongoing studies
Study	Ref.	Design	studied treatment	control treatment	patients	study risk of bias	sample sizes	Results
COVID-19 severe or critically meta-analysis
Munch (COVID-STEROID) NCT04348305		RCT	Hydrocortisone	placebo	COVID-19 severe or critically	low	16/14	no results
CAPE-COVID NCT02517489		RCT	Hydrocortisone	placebo	COVID-19 severe or critically	low	76/73	inconclusive	inconclusive 29 % decrease in death or ventilation (PE) with a high degree of certainty due to low risk of bias
1 study excluded by filtering options (1 RCT / 0 OBS)

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

Study explorer (study characteristics and results) method abbreviations pdf xlsx

COVID-19 severe or critically meta-analysis